Antitumour and antimalarial activity of artemisinin-acridine hybrids

Michael Jones, Amy E. Mercer, Paul A. Stocks, Louise J.I. La Pensée, Rick Cosstick, B. Kevin Park, Miriam E. Kennedy, Ivo Piantanida, Stephen A. Ward, Jill Davies, Patrick G. Bray, Sarah L. Rawe, Jonathan Baird, Tafadzwa Charidza, Omar Janneh, Paul M. O'Neill

    Research output: Contribution to journalArticlepeer-review

    62 Citations (Scopus)

    Abstract

    Artemisinin-acridine hybrids were prepared and evaluated for their in vitro activity against tumour cell lines and a chloroquine sensitive strain of Plasmodium falciparum. They showed a 2-4-fold increase in activity against HL60, MDA-MB-231 and MCF-7 cells in comparison with dihydroartemisinin (DHA) and moderate antimalarial activity. Strong evidence that the compounds induce apoptosis in HL60 cells was obtained by flow cytometry, which indicated accumulation of cells in the G1 phase of the cell cycle.

    Original languageEnglish
    Pages (from-to)2033-2037
    Number of pages5
    JournalBioorganic and Medicinal Chemistry Letters
    Volume19
    Issue number7
    DOIs
    Publication statusPublished - 1 Apr 2009

    Keywords

    • Acridine
    • Anticancer
    • Antimalarial
    • Apoptosis
    • Artemisinin
    • Confocal microscopy
    • DNA

    Fingerprint

    Dive into the research topics of 'Antitumour and antimalarial activity of artemisinin-acridine hybrids'. Together they form a unique fingerprint.

    Cite this